Monjuvi + Rituximab & Lenalidomide: The First and Only CD19- and CD20-targeted Immunotherapy Combination for 2L+ Follicular Lymphoma Patients

Event Date:

Aug 19, 2026

Credit Type:

--

Credits:

--
Thrombotic Risk in Patients With Polycythemia Vera | Identify When to Intervene With Jakafi® (ruxolitinib)

Event Date:

Aug 12, 2026

Credit Type:

--

Credits:

--